Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS).

9 Aug 2012

Researchers call for digital rectal exam revival

Rates of digital rectal examination are low in clinical practice and levels of sufficient training in the technique may be in decline, the results of a US study suggest.

8 Aug 2012

Hospice cancer patients adhere well to pain meds

Study results from the midwest USA indicate that hospice-treated older individuals with cancer are highly adherent to pain medication, but that as they become more comfortable, adherence wanes.

8 Aug 2012

High BMI linked to poor outcomes after prostatectomy and ADT

Men initiating androgen deprivation therapy after radical prostatectomy are more likely to experience poor outcomes if they are overweight or obese, report researchers.

8 Aug 2012

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

8 Aug 2012

GTx reports revenue of $1.6 million for second quarter 2012

GTx, Inc. today provided a Company update and reported financial results for the second quarter of 2012.

8 Aug 2012

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

Prescribing calcium and vitamin D supplements for men at risk of bone loss from hormonal treatment for prostate cancer seems like good medicine.

8 Aug 2012

New research hopes to uncover mystery behind breast cancer metastasis

If detected early, most cases of breast cancer are curable. But if the tumour has metastasized - or spread to a site outside of the breast - cure rates decline. A team of researchers from Lawson Health Research Institute and Western University have received $449,733 from the Canadian Breast Cancer Foundation - Ontario Region to study a rare subpopulation of tumour cells called cancer stem cells (CSCs) in hopes of uncovering the mystery behind metastasis.

8 Aug 2012

Older men with higher levels of free testosterone more likely to develop prostate cancer

New research finds older men with higher levels of free testosterone have an increased risk of prostate cancer. Australian researchers spent a decade exploring the testosterone-prostate cancer connection by comparing natural testosterone levels of men in their 70s and 80s, those with prostate cancer and without.

8 Aug 2012

Diagnostic imaging in stage IV cancer on the rise

Diagnostic imaging in elderly patients with stage IV cancer has increased significantly in recent years, while its use among those with early-stage disease has decreased, suggest study findings.

6 Aug 2012

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $48.2 million in new grants to investigators at UT Southwestern Medical Center to support cancer-related projects and to recruit pre-eminent cancer researchers.

6 Aug 2012

Potential drug targets and prognostic markers for prostate cancer

Two proteins that act in opposing directions - one that promotes cancer and one that suppresses cancer - regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.

6 Aug 2012

Scientists identify key factor that drives resistance to cancer drug

Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors - such as those of the breast, prostate, lung and colon - that have metastasized, or spread, throughout the body. A team of scientists led by Fred Hutchinson Cancer Research Center has discovered a key factor that drives this drug resistance - information that ultimately may be used to improve the effectiveness of therapy and buy precious time for patients with advanced cancer.

6 Aug 2012

Simpler and more accurate way to test for prostate cancer

An undergraduate student's technique for detecting certain metabolites in urine samples could lead to a simpler and more accurate way to test for prostate cancer.

3 Aug 2012

Advanced cancer patients able to state their own pain goals

Advanced cancer patients are successfully able to express their desired level of pain relief on a scale of 1–10, indicating that personalized pain goals could be a novel target for pain treatment response, say researchers.

2 Aug 2012

Surgery avoidable for some with persistent incontinence after prostatectomy

Researchers have identified factors that could help determine whether patients who have not recovered urinary continence more than 1 year after undergoing radical prostatectomy should undergo further surgery.

1 Aug 2012

Opinion of artificial hydration varies by ethnicity

Ethnicity influences whether patients at the end of life and their carers view artificial hydration as food or medicine, with more individuals from ethnic minorities viewing it as food than non-Hispanic European Americans, show US study results.

1 Aug 2012

MDxHealth’s Irvine, California and CLIA laboratory receive CAP accreditation

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.

1 Aug 2012

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

31 Jul 2012

PSA testing and early detection may prevent 17,000 men each year from prostate cancer

A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.

30 Jul 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Researchers call for digital rectal exam revival

Hospice cancer patients adhere well to pain meds

High BMI linked to poor outcomes after prostatectomy and ADT

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

GTx reports revenue of $1.6 million for second quarter 2012

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

New research hopes to uncover mystery behind breast cancer metastasis

Older men with higher levels of free testosterone more likely to develop prostate cancer

Diagnostic imaging in stage IV cancer on the rise

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

Potential drug targets and prognostic markers for prostate cancer

Scientists identify key factor that drives resistance to cancer drug

Simpler and more accurate way to test for prostate cancer

Advanced cancer patients able to state their own pain goals

Surgery avoidable for some with persistent incontinence after prostatectomy

Opinion of artificial hydration varies by ethnicity

MDxHealth’s Irvine, California and CLIA laboratory receive CAP accreditation

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

PSA testing and early detection may prevent 17,000 men each year from prostate cancer

What to know about prostate cancer eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in